Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Teva Parenteral Medicines, Inc.

NDC labeler code: 0703

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

27Products (NDC)

Prescription medicines

FDA applications for these products

  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
ApprovedApplicationMedicineSponsor
September 26, 2019ANDA206648 Treprostinil
TREPROSTINIL
Teva Pharms USA
October 5, 2018ANDA209852 Triamcinolone acetonide
TRIAMCINOLONE ACETONIDE
Teva Pharms USA
March 23, 2018ANDA090713 Palonosetron hydrochloride
PALONOSETRON HYDROCHLORIDE
Teva Pharms USA
January 8, 2010ANDA040843 Methotrexate
METHOTREXATE SODIUM PRESERVATIVE FREE
Pharmachemie Bv
June 17, 2008ANDA078591 Hydromorphone hydrochloride
HYDROMORPHONE HYDROCHLORIDE
Hospira Inc
October 14, 2004ANDA077269 Carboplatin
CARBOPLATIN
Pharmachemie Bv
January 25, 2002ANDA075184 Paclitaxel
PACLITAXEL
Teva Pharms
May 16, 2000ANDA074656 Cisplatin
CISPLATIN
Pharmachemie Bv
November 27, 1991ANDA073135 Metoclopramide
METOCLOPRAMIDE HYDROCHLORIDE
Teva Pharms USA
October 31, 1991ANDA073303 Sulfamethoxazole and trimethoprim
SULFAMETHOXAZOLE AND TRIMETHOPRIM
Teva Pharms USA

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2021

  1. July 29, 2021 · Class II · Terminated · D-0741-2021 · Metoclopramide

    Lack of Assurance of Sterility

    Metoclopramide Injection USP, 10 mg/2mL (5 mg/mL) 2 mL single-use vial, Rx only, Teva Parenteral Medicines, Inc. Irvine, CA 92618, NDC 0703-4502-01

  2. April 26, 2021 · Class II · Terminated · D-0377-2021 · Metoclopramide

    Lack of Assurance of Sterility

    Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial, Rx Only, TEVA Parenteral Medicines, Inc. Irvine, CA 92618 NDC 0703-4502-04

  3. February 15, 2021 · Class II · Terminated · D-0297-2021 · Metoclopramide

    Chemical contamination; Unknown brown residue adhering to the inside of one vial.

    Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceuticals, USA, Inc., Parsippany, NJ Vial NDC 0703-4502-01 (vial) NDC# 0703-4502-04 (tray)

  4. February 10, 2021 · Class II · Terminated · D-0277-2021 · Metoclopramide

    Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

    Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial NDC 0703-4502-01), packaged in 25 x 2 mL Single-Use Vials per tray (NDC 0703-4502-04), Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618.

2018

  1. February 7, 2018 · Class I · Terminated · D-0596-2018 · Hydromorphone hydrochloride

    Non-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked.

    Hydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High Potency Formulation. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618. NDC: 0703-0110-01

2017

  1. July 26, 2017 · Class II · Terminated · D-1080-2017 · Hydromorphone hydrochloride

    Presence of Particulate Matter: Silicone oil

    Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA. NDC: 0703-0018-01

  2. July 26, 2017 · Class II · Terminated · D-1082-2017 · Hydromorphone hydrochloride

    Presence of Particulate Matter: Silicone oil

    Hydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL), 5 mL Single Dose Vial.(10 vials per carton NDC 0703-0113-01) and 180 vials per case (NDC 0703-0113-03) Mfd By: Hospira, Inc., Lake Forest, IL 60045 USA,

2014

  1. October 1, 2014 · Class II · Terminated · D-0044-2015 · Hydromorphone hydrochloride

    Lack Of Assurance Of Sterility: Confirmed customer complaints of glass product container vials that may be broken or cracked.

    Hydromorphone Hydrochloride Injection, USP, 10 mg/mL, Rx only, packaged in a) 1 mL Single-dose Vial (NDC 0703-0110-01), packaged in 10 x 1 mL Single-dose Vials per carton (NDC 0703-0110-03); Mfd By: Hospira Inc., Lake Fo

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026

FDA Enforcement Report search → · Report an error →